Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: A prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques

Radiology

Volumn 274, Issue 3, 2015, Pages 712-722

  Kim, Hye Jin ^a,b   Lee, Seung Soo ^a   Byun, Jae Ho ^a   Kim, Jin Cheon ^a   Yu, Chang Sik ^a   Park, Seong Ho ^a   Kim, Ah Young ^a   Ha, Hyun Kwon ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Eulji General Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; GADOXETIC ACID;

ADULT; AGED; COLORECTAL TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DIFFUSION WEIGHTED IMAGING; EVALUATION STUDY; FEMALE; HUMAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; SECONDARY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84924326328     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14140390     Document Type: Article

References (34)

1. Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010;28(3):493-508
2. Adam R, Aloia T, Lévi F, et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 2007;25(29):4593-4602
3. Chong G, Cunningham D. Improving longterm outcomes for patients with liver metastases from colorectal cancer. J Clin Oncol 2005;23(36):9063-9066
4. Zech CJ, Grazioli L, Jonas E, et al. Healtheconomic evaluation of three imaging strategies in patients with suspected colorectal liver metastases: Gd-EOB-DTPA-enhanced MRI vs. extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany, Italy and Sweden. Eur Radiol 2009;19(suppl 3):S753-S763
5. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: Diffusion-weighted sensitivityencoding versus SPIO-enhanced MR imaging. Radiology 2006;239(1):122-130
6. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: Comparison with standard breath-hold T2- weighted imaging. Radiology 2008;246(3): 812-822
7. Motosugi U, Ichikawa T, Morisaka H, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: Comparison with contrastenhanced multi-detector row CT. Radiology 2011;260(2):446-453
8. Ichikawa T, Saito K, Yoshioka N, et al. Detection and characterization of focal liver lesions: A Japanese phase III, multicenter comparison between gadoxetic acid disodium- enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 2010;45(3):133-141
9. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: Comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008;18(3): 457-467
10. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230(1): 266-275
11. Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: A meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010;257(3):674-684
12. Löwenthal D, Zeile M, Lim WY, et al. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: Comparison of diffusion-weighted and Gd- EOB-DTPA enhanced MR imaging. Eur Radiol 2011;21(4):832-840
13. Chung WS, Kim MJ, Chung YE, et al. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases. J Magn Reson Imaging 2011;34(2):345-353
14. Muhi A, Ichikawa T, Motosugi U, et al. Diagnosis of colorectal hepatic metastases: Comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging 2011;34(2):326-335
15. Donati OF, Hany TF, Reiner CS, et al. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: Comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med 2010;51(5):692-699
16. Kim YK, Lee MW, Lee WJ, et al. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter). Invest Radiol 2012;47(3):159-166
17. Glimelius B, Pãhlman L, Cervantes A; ESMO Guidelines Working Group. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(suppl 5):v82-v86
18. Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases. Gut 2006;55(suppl 3): Iii1-iii8
19. Dodd GD 3rd. An American's guide to Couinaud's numbering system. AJR Am J Roentgenol 1993;161(3):574-575
20. Onishi H, Murakami T, Kim T, et al. Hepatic metastases: Detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology 2006;239(1):131-138
21. Rappeport ED, Loft A, Berthelsen AK, et al. Contrast-enhanced FDG-PET/CT vs. SPIOenhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: A prospective study with intraoperative confirmation. Acta Radiol 2007;48(4): 369-378
22. Ward J, Robinson PJ, Guthrie JA, et al. Liver metastases in candidates for hepatic resection: Comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 2005;237(1):170-180
23. Goshima S, Kanematsu M, Watanabe H, et al. Hepatic hemangioma and metastasis: Differentiation with gadoxetate disodiumenhanced 3-T MRI. AJR Am J Roentgenol 2010;195(4):941-946
24. Hardie AD, Naik M, Hecht EM, et al. Diagnosis of liver metastases: value of diffusion- weighted MRI compared with gadolinium- enhanced MRI. Eur Radiol 2010;20(6): 1431-1441
25. Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, Togashi K. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 2010;20(11):2690-2698
26. Coenegrachts K, ter Beek L, Haspeslagh M, Bipat S, Stoker J, Rigauts H. Comparison of respiratory-triggered T2-weighted turbo spin-echo imaging versus breath-hold T2- weighted turbo spin-echo imaging: Distinguishing benign from malignant liver lesions in patients with colorectal cancer. JBR-BTR 2009;92(4):195-201
27. Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 2007;25(4):848-858
28. Miller FH, Hammond N, Siddiqi AJ, et al. Utility of diffusion-weighted MRI in distinguishing benign and malignant hepatic lesions. J Magn Reson Imaging 2010;32(1):138-147
29. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254(1): 47-66
30. Chakraborty DP. Recent advances in observer performance methodology: jackknife free-response ROC (JAFROC). Radiat Prot Dosimetry 2005;114(1-3):26-31
31. Chakraborty DP. New developments in observer performance methodology in medical imaging. Semin Nucl Med 2011;41(6): 401-418
32. Chakraborty DP, Berbaum KS. Observer studies involving detection and localization: modeling, analysis, and validation. Med Phys 2004;31(8):2313-2330
33. Bartolozzi C, Donati F, Cioni D, et al. Detection of colorectal liver metastases: A prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT. Eur Radiol 2004;14(1):14-20
34. Scharitzer M, Ba-Ssalamah A, Ringl H, et al. Preoperative evaluation of colorectal liver metastases: Comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol 2013;23(8): 2187-2196.